The most remarkable finding from this study is that the miR-22-3p/galectin-1 axis affects cancer progression by regulating the cell cycle in hormone receptor-positive breast cancers and by affecting EMT mechanisms in triple-negative breast cancers. Here, LGALS1 is linked to triple-negative breast carcinoma.